← Peptide library

Peptide comparison

BPC-157 vs TB-500

BPC-157 vs TB-500

This page compares BPC-157 and TB-500, two research peptides, and collects reconstitution and dosing-reference data reported for each. It is provided strictly for informational and harm-reduction purposes and is not medical advice. Neither compound is FDA-approved, and the entries below summarize regulatory status, available evidence, and the limited dosing references on record rather than recommending any use.

BPC-157

TB-500

Regulatory status

Regulatory status

Not FDA-approved; FDA reports limited safety information

Not FDA-approved; FDA lists the TB-500 fragment as a potential significant compounding safety risk

Evidence tier

Evidence tier

Extremely limited human data

No identified human exposure data for TB-500 fragment

Route

Route

No established injectable treatment route

No established human route

Frequency

Frequency

No established regimen

No established regimen

Study / label range

Study / label range

No established range

No established range

Key differences

Neither peptide is FDA-approved: the FDA reports limited safety information for BPC-157, while it lists the TB-500 (LKKTETQ) fragment as a potential significant compounding safety risk. The evidence tiers differ in degree but are both minimal, with BPC-157 having extremely limited human data and the TB-500 (LKKTETQ) fragment having no identified human exposure data. This summary reflects only the regulatory status and evidence tier on record for each compound and does not establish, compare, or recommend any use, route, or dose.

Open BPC-157 calculator

Open TB-500 calculator

BPC-157 reference

TB-500 reference

Reference comparison only. Not medical advice; verify with a clinician, product label, pharmacist, or approved research protocol.

Frequently asked questions

How are BPC-157 and TB-500 administered?

Neither has an established human treatment route or regimen. Both are research peptides that are not FDA-approved, and the FDA has flagged safety concerns — including listing the TB-500 fragment as a potential significant compounding safety risk. The table above summarizes this.

What dose range does this comparison reference?

Neither compound has an established dose range, so none is quoted. The calculator can still perform the arithmetic for whatever inputs you enter, but it does not imply any figure is a recommended dose.

Can I calculate reconstitution for both here?

Yes — the buttons above open each calculator to convert vial strength and bacteriostatic water into concentration (mg/mL), draw volume and U-100 syringe units. It is arithmetic only.

Does this page recommend either peptide?

No. It is a neutral reference that reflects the limited information available, and it does not assess safety, efficacy, or suitability. Consult a qualified professional and review the FDA’s safety statements.